VYNCEDE
LIVE

Serial Number

79186798

Owner

NOVARTIS AG

Filing Date

Feb 5, 2016

Add to watchlist:

No watchlists yet
View on USPTO

VYNCEDE Trademark

Serial Number: 79186798 • Registration: 5038616

VYNCEDE is a trademark filed by NOVARTIS AG on February 5, 2016. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

NOVARTIS AG (7,166 trademarks)

CH-4002
BASEL , CH

Entity Type: 03

Trademark Details

Filing Date

February 5, 2016

Registration Date

September 13, 2016

Published for Opposition

June 28, 2016

Cancellation Date

December 12, 2019

Goods & Services

Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; anti-fungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical products; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastrointestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculoskeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical products for ophthalmological use; pharmaceutical products for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and the treatment of allergies; pharmaceutical products for the prevention and treatment of bone diseases; pharmaceutical products for the prevention and treatment of respiratory diseases and asthma

Filing History

INTERNATIONAL REGISTRATION RENEWED
Dec 11, 2025 RNWL
NOTIFICATION PROCESSED BY IB
Oct 2, 2020 GPNX
NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED
Dec 27, 2019 DENC
DEATH OF INTERNATIONAL REGISTRATION
Dec 27, 2019 DETH
NOTIFICATION PROCESSED BY IB
Nov 18, 2016 GPNX
FINAL DISPOSITION NOTICE SENT TO IB
Nov 3, 2016 FICS
FINAL DISPOSITION PROCESSED
Nov 3, 2016 FIMP
GRANT OF PROTECTION CREATED, TO BE SENT TO IB
Oct 13, 2016 GPAR
REGISTERED-PRINCIPAL REGISTER
Sep 13, 2016 R.PR
PUBLISHED FOR OPPOSITION
Jun 28, 2016 PUBO
NOTICE OF PUBLICATION
Jun 8, 2016 NPUB
APPLICATION FILING RECEIPT MAILED
May 24, 2016 MAFR
APPROVED FOR PUB - PRINCIPAL REGISTER
May 22, 2016 CNSA
ASSIGNED TO EXAMINER
May 20, 2016 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 20, 2016 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
May 19, 2016 LIMI
SN ASSIGNED FOR SECT 66A APPL FROM IB
May 19, 2016 REPR